Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Repeated intensified infliximab induction - results from an 11-year prospective study of ulcerative colitis using a novel treatment algorithm.

Johnsen KM, Goll R, Hansen V, Olsen T, Rismo R, Heitmann R, Gundersen MD, Kvamme JM, Paulssen EJ, Kileng H, Johnsen K, Florholmen J.

Eur J Gastroenterol Hepatol. 2017 Jan;29(1):98-104.

PMID:
27749779
2.

Loss of interleukin 33 expression in colonic crypts - a potential marker for disease remission in ulcerative colitis.

Gundersen MD, Goll R, Hol J, Olsen T, Rismo R, Sørbye SW, Sundnes O, Haraldsen G, Florholmen J.

Sci Rep. 2016 Oct 17;6:35403. doi: 10.1038/srep35403.

3.

Normalization of mucosal tumor necrosis factor-α: A new criterion for discontinuing infliximab therapy in ulcerative colitis.

Olsen T, Rismo R, Gundersen MD, Paulssen EJ, Johnsen K, Kvamme JM, Goll R, Florholmen J.

Cytokine. 2016 Mar;79:90-5. doi: 10.1016/j.cyto.2015.12.021. Epub 2016 Jan 8.

PMID:
26775117
4.

Dynamics of the IL-33/ST2 network in the progression of human colorectal adenoma to sporadic colorectal cancer.

Cui G, Qi H, Gundersen MD, Yang H, Christiansen I, Sørbye SW, Goll R, Florholmen J.

Cancer Immunol Immunother. 2015 Feb;64(2):181-90. doi: 10.1007/s00262-014-1624-x. Epub 2014 Oct 17.

PMID:
25324197
5.

Expression of thyroid transcription factor-1 is associated with a basal-like phenotype in breast carcinomas.

Klingen TA, Chen Y, Suhrke P, Stefansson IM, Gundersen MD, Akslen LA.

Diagn Pathol. 2013 May 15;8:80. doi: 10.1186/1746-1596-8-80.

6.

Incidence and clinical features of amyotrophic lateral sclerosis in Møre and Romsdal County, Norway.

Gundersen MD, Yaseen R, Midgard R.

Neuroepidemiology. 2011;37(1):58-63. doi: 10.1159/000329523. Epub 2011 Aug 22.

PMID:
21860251
7.

Thyroid transcription factor-1 positive primary breast cancer: a case report with review of the literature.

Klingen TA, Chen Y, Gundersen MD, Aas H, Westre B, Sauer T.

Diagn Pathol. 2010 Jun 17;5:37. doi: 10.1186/1746-1596-5-37. Review.

Supplemental Content

Loading ...
Support Center